查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1485211

2024 年智慧 DDS（药物传输系统）全球市场报告

Smart Drug Delivery Systems Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

智慧DDS（药物传输系统）的市场规模预计在未来几年将快速成长。 2028年，将以19.7%的复合年增长率成长至259.4亿美元。预测期内的预期增长是由非传染性疾病负担增加、对精准医疗的日益关注、温度测量的增加、对非侵入性给药方法的需求不断增长以及医疗保健支出的持续增长等因素推动的。由于多种因素。这段时期的主要趋势包括小型化和微加工技术的进步、材料科学的创新、人工智慧（AI）和机器学习（ML）的整合、奈米药物输送系统的开发以及物联网和可穿戴设备的集成。

慢性病盛行率的不断上升将推动智慧 DDS（药物传输系统）市场的成长。慢性病的特征是长期的健康状况，进展缓慢且原因复杂，并且由于老化、环境影响和获得医疗保健方面的差异等因素而呈上升趋势。智慧 DDS（药物输送系统）透过提高药物疗效和提高患者依从性，为慢性病管理提供了一个有前景的解决方案。例如，国家医学图书馆的资料预测，到 2050 年，患有至少一种慢性病的人数将大幅增加，从而推动智慧 DDS（药物输送系统）市场的发展。

智慧 DDS（药物输送系统）市场的主要参与者专注于开发创新的可重复使用的药物输送设备，这将彻底改变药物管理。其中之一是 Qfinity，这是一种可重复使用的药物输送装置，设计用于皮下自我给药。 Qfinity 可用于多次注射，而不是一次性使用，从而减少废弃物并提供环境效益。例如，捷普公司于 2022 年 5 月推出了 Qfinity。该设备每台可进行 100 多次进样，并与各种预填充药筒相容。该设备不仅减少每次注射的碳排放，而且具有适应不同药物体积和黏度的多功能性。此外，连网型版本 Qfinity+ 可以远端监控患者照护以及内建感测器和电子设备的合规性，确保连接性而不影响易用性。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球智慧DDS（药物传输系统）市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球智慧DDS（药物传输系统）市场表现：规模与成长，2018-2023
  • 全球智慧DDS（药物传输系统）市场预测：规模与成长，2023-2028，2033F

第六章 市场细分

  • 全球智慧DDS（药物传输系统）市场：按产品分類的绩效与预测，2018-2023、2023-2028F、2033F
  • 连接吸入器
  • 连接自动注射器
  • 连接笔式註射器
  • 连接的可穿戴注射器
  • 附加元件感测器
  • 其他产品
  • 全球智慧DDS（药物传递系统）市场：依治疗领域分類的表现与预测，2018-2023、2023-2028F、2033F
  • 代谢紊乱
  • 神经系统疾病
  • 呼吸系统疾病
  • 荷尔蒙失调
  • 其他治疗领域
  • 全球智慧DDS（药物传递系统）市场：按药物传输模式分類的实际和预测，2018-2023、2023-2028F、2033F
  • 注射
  • 吸入
  • 口服
  • 全球智慧DDS（药物传输系统）市场：最终用户的表现与预测，2018-2023、2023-2028F、2033F
  • 医院
  • 诊所
  • 居家照护
  • 门诊就诊环境
  • 其他最终用户

第 7 章 区域/国家分析

  • 全球智慧DDS（药物传输系统）市场：按地区分類的绩效与预测，2018-2023、2023-2028F、2033F
  • 全球智慧DDS（药物传输系统）市场：按国家分類的绩效与预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 智慧DDS（药物传输系统）市场：竞争格局
  • 智慧 DDS（药物传输系统）市场：公司简介
    • Pfizer Inc
    • Johnson & Johnson
    • Bayer AG
    • Abbott Laboratories
    • Novartis International AG

第三十一章 其他重大及创新企业

  • Medtronic plc
  • Eli Lilly and Company
  • Amgen Inc
  • Novo Nordisk
  • Merck Group
  • Becton Dickinson and Company
  • Stryker Corporation
  • Baxter International Inc
  • Boston Scientific Corporation
  • Biogen Inc
  • Vertex Pharmaceuticals Incorporated
  • Phillips-Medisize Corporation
  • ResMed Inc.
  • West Pharmaceutical Services Inc
  • Insulet Corporation

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r17438

Smart drug delivery systems encompass advanced technologies aimed at enhancing the efficacy, safety, and targeted delivery of pharmaceutical compounds within the body. These systems utilize diverse approaches to regulate drug release, improve bioavailability, and minimize adverse effects.

The primary products within smart drug delivery systems include connected inhalers, connected autoinjectors, connected pen injectors, connected wearable injectors, add-on sensors, and other related devices. Connected inhalers, for instance, are electronic monitoring systems integrated into inhalers, which track drug usage and may provide feedback on device technique. These systems find applications across various therapeutic areas such as metabolic disorders, neurological disorders, respiratory disorders, hormonal disorders, and more. They can deliver drugs via different modes including injectable, inhalation, and oral routes, and cater to a range of end users including hospitals, clinics, home care settings, ambulatory care facilities, among others.

The smart drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides smart drug delivery systems market statistics, including smart drug delivery systems industry global market size, regional shares, competitors with smart drug delivery systems market share, detailed smart drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the smart drug delivery systems industry. This smart drug delivery systems market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart drug delivery systems market size has grown rapidly in recent years. It will grow from $10.61 billion in 2023 to $12.65 billion in 2024 at a compound annual growth rate (CAGR) of 19.2%. The growth observed during the historic period can be attributed to several factors, including the increasing demand for drug delivery systems, rising patient compliance with treatment regimens, the growing prevalence of chronic diseases, the rise of personalized medicine approaches, and the need for cost-effective healthcare solutions.

The smart drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $25.94 billion in 2028 at a compound annual growth rate (CAGR) of 19.7%. The anticipated growth in the forecast period can be attributed to several factors, including the growing burden of non-communicable diseases, an increased focus on precision medicine, the rise of theragnostics, a growing demand for non-invasive drug delivery methods, and the continual increase in healthcare expenditure. Major trends expected during this period include advancements in miniaturization and microfabrication technologies, innovations in material science, the integration of artificial intelligence (AI) and machine learning (ML), the development of nano-sized drug delivery systems, and the integration of IoT and wearable technology into drug delivery systems.

The increasing prevalence of chronic diseases is poised to drive the growth of the smart drug delivery systems market. Chronic diseases, characterized by long-term health conditions with slow progression and complex causes, are on the rise due to factors such as aging populations, environmental influences, and disparities in healthcare access. Smart drug delivery systems offer a promising solution for managing chronic diseases by enhancing medication effectiveness and improving patient adherence. For example, data from the National Library of Medicine forecasts a substantial increase in the number of individuals with at least one chronic illness by 2050, underscoring the significant role of rising chronic disease prevalence in propelling the smart drug delivery systems market.

Key players in the smart drug delivery systems market are focused on developing innovative reusable drug delivery devices to revolutionize drug administration. One such device is Qfinity, a reusable drug delivery device designed for subcutaneous self-administration of medication. Unlike single-use devices, Qfinity can be utilized for multiple injections, reducing waste and offering environmental benefits. For instance, Jabil Inc. launched Qfinity in May 2022, featuring the capability to handle over 100 injections per device and accommodating various pre-filled cartridges. The device not only reduces the carbon footprint per injection but also offers versatility in handling different drug volumes and viscosities. Additionally, the connected version, Qfinity+, enables remote monitoring of patient care and compliance through built-in sensors and electronics, ensuring connectivity without compromising ease of use.

In October 2023, Novo Nordisk A/S strengthened its position in the smart drug delivery systems market through the acquisition of Biocorp Production SA for $164.5 million. This strategic move aims to augment Novo Nordisk's capabilities in developing innovative connected devices and delivery solutions, exemplified by Mallya, a smart add-on device for pen injectors. Biocorp, a France-based designer and manufacturer of medical devices and drug delivery systems, brings expertise in connected devices that align with Novo Nordisk's focus on advancing drug delivery technologies to enhance patient care and treatment outcomes.

Major companies operating in the smart drug delivery systems market are Pfizer Inc, Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc, Boston Scientific Corporation, Biogen Inc, Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc, Insulet Corporation, Owen Mumford Ltd, Sonceboz, H&T Presspart Manufacturing Ltd, E3D Elcam Drug Delivery Devices, CeQur Corporation

North America was the largest region in the smart drug delivery systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the smart drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart drug delivery systems market consists of revenues earned by entities by providing services such as personalized drug delivery, targeted treatment, diagnostic integration, remote monitoring, and feedback mechanisms. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart drug delivery systems market also includes sales of products including microfluidic devices, transdermal drug delivery patches, electroceutical devices, and remote-controlled drug delivery devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

  • Including: 1) By Product: Connected Inhalers; Connected Autoinjectors; Connected Pen Injectors; Connected Wearable Injectors; Add-On Sensors
  • 2) By Therapeutic Area: Metabolic Disorders; Neurological Disorders; Respiratory Disorders; Hormonal Disorders
  • 3) By Drug Delivery Mode: Injectable; Inhalation; Oral
  • 4) By End-User: Hospitals; Clinics; Home Care; Ambulatory Care Settings
  • Covering: Pfizer Inc.; Johnson & Johnson; Bayer AG; Abbott Laboratories; Novartis International AG

Table of Contents

1. Executive Summary

2. Smart Drug Delivery Systems Market Characteristics

3. Smart Drug Delivery Systems Market Trends And Strategies

4. Smart Drug Delivery Systems Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Smart Drug Delivery Systems Market Size and Growth

  • 5.1. Global Smart Drug Delivery Systems Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Smart Drug Delivery Systems Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Smart Drug Delivery Systems Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Smart Drug Delivery Systems Market Segmentation

  • 6.1. Global Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Connected Inhalers
  • Connected Autoinjectors
  • Connected Pen Injectors
  • Connected Wearable Injectors
  • Add-On Sensors
  • Other Products
  • 6.2. Global Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Metabolic Disorders
  • Neurological Disorders
  • Respiratory Disorders
  • Hormonal Disorders
  • Other Therapeutic Areas
  • 6.3. Global Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Injectable
  • Inhalation
  • Oral
  • 6.4. Global Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Home Care
  • Ambulatory Care Settings
  • Other End-Users

7. Smart Drug Delivery Systems Market Regional And Country Analysis

  • 7.1. Global Smart Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Smart Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Smart Drug Delivery Systems Market

  • 8.1. Asia-Pacific Smart Drug Delivery Systems Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Smart Drug Delivery Systems Market

  • 9.1. China Smart Drug Delivery Systems Market Overview
  • 9.2. China Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Smart Drug Delivery Systems Market

  • 10.1. India Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Smart Drug Delivery Systems Market

  • 11.1. Japan Smart Drug Delivery Systems Market Overview
  • 11.2. Japan Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Smart Drug Delivery Systems Market

  • 12.1. Australia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Smart Drug Delivery Systems Market

  • 13.1. Indonesia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Smart Drug Delivery Systems Market

  • 14.1. South Korea Smart Drug Delivery Systems Market Overview
  • 14.2. South Korea Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Smart Drug Delivery Systems Market

  • 15.1. Western Europe Smart Drug Delivery Systems Market Overview
  • 15.2. Western Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Smart Drug Delivery Systems Market

  • 16.1. UK Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Smart Drug Delivery Systems Market

  • 17.1. Germany Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Smart Drug Delivery Systems Market

  • 18.1. France Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Smart Drug Delivery Systems Market

  • 19.1. Italy Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Smart Drug Delivery Systems Market

  • 20.1. Spain Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Smart Drug Delivery Systems Market

  • 21.1. Eastern Europe Smart Drug Delivery Systems Market Overview
  • 21.2. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Smart Drug Delivery Systems Market

  • 22.1. Russia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Smart Drug Delivery Systems Market

  • 23.1. North America Smart Drug Delivery Systems Market Overview
  • 23.2. North America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Smart Drug Delivery Systems Market

  • 24.1. USA Smart Drug Delivery Systems Market Overview
  • 24.2. USA Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Smart Drug Delivery Systems Market

  • 25.1. Canada Smart Drug Delivery Systems Market Overview
  • 25.2. Canada Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Smart Drug Delivery Systems Market

  • 26.1. South America Smart Drug Delivery Systems Market Overview
  • 26.2. South America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Smart Drug Delivery Systems Market

  • 27.1. Brazil Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Smart Drug Delivery Systems Market

  • 28.1. Middle East Smart Drug Delivery Systems Market Overview
  • 28.2. Middle East Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Smart Drug Delivery Systems Market

  • 29.1. Africa Smart Drug Delivery Systems Market Overview
  • 29.2. Africa Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Smart Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 30.1. Smart Drug Delivery Systems Market Competitive Landscape
  • 30.2. Smart Drug Delivery Systems Market Company Profiles
    • 30.2.1. Pfizer Inc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis International AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Smart Drug Delivery Systems Market Other Major And Innovative Companies

  • 31.1. Medtronic plc
  • 31.2. Eli Lilly and Company
  • 31.3. Amgen Inc
  • 31.4. Novo Nordisk
  • 31.5. Merck Group
  • 31.6. Becton Dickinson and Company
  • 31.7. Stryker Corporation
  • 31.8. Baxter International Inc
  • 31.9. Boston Scientific Corporation
  • 31.10. Biogen Inc
  • 31.11. Vertex Pharmaceuticals Incorporated
  • 31.12. Phillips-Medisize Corporation
  • 31.13. ResMed Inc.
  • 31.14. West Pharmaceutical Services Inc
  • 31.15. Insulet Corporation

32. Global Smart Drug Delivery Systems Market Competitive Benchmarking

33. Global Smart Drug Delivery Systems Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Smart Drug Delivery Systems Market

35. Smart Drug Delivery Systems Market Future Outlook and Potential Analysis

  • 35.1 Smart Drug Delivery Systems Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Smart Drug Delivery Systems Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Smart Drug Delivery Systems Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer